29th ESGCT Annual Congress
Dall’11 al 14 ottobre 2022, ReiThera parteciperà al 29° Congresso ESGCT in collaborazione con la British Society for Gene & Cell Therapy nell’ International Conference Centre di Edimburgo. [...]
Safety and immune response kinetics of GRAd-COV2 vaccine: phase 1 clinical trial results
Despite the successful deployment of efficacious vaccines and therapeutics, the development of novel vaccines for SARS-CoV-2 remains a major goal to increase vaccine doses availability and [...]
Engineered Sleeping Beauty Transposon as Efficient System to Optimize Chimp Adenoviral Production
Sleeping Beauty (SB) is the first DNA transposon employed for efficient transposition in vertebrate cells, opening new applications for genetic engineering and gene therapies. A transposonbased [...]
Uno studio Unimore, in collaborazione con l’azienda biotecnologica ReiThera, ha ottimizzato la produzione di vettori Adenovirali usati in trial clinici per malattie infettive, tra cui COVID-19
Un lavoro svolto da un team Unimore composto dalle Dott.sse Daniela Benati, Samantha Baldassarri, Clarissa Patrizi e Eleonora Cattin e coordinato dalla Prof.ssa Alessandra Recchia in [...]
Approvato il progetto di ReiThera, in risposta all’Avviso Pubblico della Regione Lazio “Voucher Diagnosi Digitale”
La Regione Lazio con l’avviso pubblico “Contributi per il sostegno dei processi di digitalizzazione delle imprese del Lazio – Voucher Diagnosi Digitale” intende sostenere la [...]
ReiThera and Exothera Collaborate to Develop Large-scale, Low Cost per Dose Manufacturing Process to Deliver Novel Vaccines to Low- and Middle- Income Countries
ReiThera and Exothera Collaborate to Develop Large-scale, Low Cost per Dose Manufacturing Process to Deliver Novel Vaccines to Low- and Middle- Income Countries Collaboration awarded €3 million [...]
Strong immunogenicity of heterologous prime-boost immunizations with the experimental vaccine GRAd-COV2 and BNT162b2 or ChAdOx1-nCOV19
Originally published on npj Vaccines volume 6, Article number: 131 (2021). Chiara Agrati, Stefania Capone, Concetta Castilletti, Eleonora Cimini, Giulia Matusali, Silvia Meschi, Eleonora [...]
GRAd-COV2, a gorilla adenovirus-based candidate vaccine against COVID-19, is safe and immunogenic in younger and older adults
Originally published on Sci Transl Med. 2021 Oct 26. doi: 10.1126/scitranslmed. abj1996.
Immunogenicity of a new gorilla adenovirus vaccine candidate for COVID-19
Originally published on Molecular Therapy Volume 29, Issue 8, 4 August 2021, Pages 2412-2423 Stefania Capone, Angelo Raggioli, Michela Gentile, Simone Battella, Armin Lahm, Andrea Sommella, [...]
